Marc Nascoff

Marc Nascoff

Company: Fortis Therapeutics

Job title: Chief Scientific Officer

Seminars:

Assessing an Anti-CD46 ADC – Pre-Clinical & Phase 1 Clinical Results In mCRPC 12:30 pm

Sharing novel immunomodulatory target Presenting pre-clinical development programme Phase 1a/1b Clinical Results in mCRPCRead more

day: Track C - Day 2

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.